- Home
- PCVX vs HSIC Comparison
PCVX vs HSIC Comparison
Compare PCVX & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- HSIC
- Stock Information
- Founded
- PCVX 2013
- HSIC 1932
- Country
- PCVX United States
- HSIC United States
- Employees
- PCVX N/A
- HSIC N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- HSIC Medical Specialities
- Sector
- PCVX Health Care
- HSIC Health Care
- Exchange
- PCVX Nasdaq
- HSIC Nasdaq
- Market Cap
- PCVX 14.7B
- HSIC 8.9B
- IPO Year
- PCVX 2020
- HSIC 1995
- Fundamental
- Price
- PCVX $106.97
- HSIC $70.90
- Analyst Decision
- PCVX Strong Buy
- HSIC Buy
- Analyst Count
- PCVX 7
- HSIC 10
- Target Price
- PCVX $147.50
- HSIC $77.50
- AVG Volume (30 Days)
- PCVX 636.4K
- HSIC 1.1M
- Earning Date
- PCVX 11-04-2024
- HSIC 11-05-2024
- Dividend Yield
- PCVX N/A
- HSIC N/A
- EPS Growth
- PCVX N/A
- HSIC N/A
- EPS
- PCVX N/A
- HSIC 2.70
- Revenue
- PCVX N/A
- HSIC $12,487,000,000.00
- Revenue This Year
- PCVX N/A
- HSIC $6.71
- Revenue Next Year
- PCVX N/A
- HSIC $4.52
- P/E Ratio
- PCVX N/A
- HSIC $26.03
- Revenue Growth
- PCVX N/A
- HSIC N/A
- 52 Week Low
- PCVX $46.16
- HSIC $60.01
- 52 Week High
- PCVX $121.06
- HSIC $82.63
- Technical
- Relative Strength Index (RSI)
- PCVX 39.76
- HSIC 50.47
- Support Level
- PCVX $102.84
- HSIC $70.07
- Resistance Level
- PCVX $115.56
- HSIC $71.58
- Average True Range (ATR)
- PCVX 3.32
- HSIC 1.32
- MACD
- PCVX -1.41
- HSIC -0.09
- Stochastic Oscillator
- PCVX 21.55
- HSIC 43.79
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.
About HSIC Henry Schein Inc.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services primarily to office-based dental and medical practitioners, as well as alternate sites of care. The company operates in two reportable segments; health care distribution and technology & value-added services. The healthcare distribution segment is engaged in combining global dental and medical businesses and distributes consumable products, small equipment, laboratory products, and Vitamins. The technology and value-added services reportable segment provides software, technology & other value-added services to health care practitioners. The majority of revenue is derived from the health care distribution segment.